BrainsWay Ltd.

BrainsWay Ltd. (BWAY) Stock Overview

Explore BrainsWay Ltd.’s financial performance, market position, analyst ratings, and future outlook.

BWAYNASDAQ
HealthcareMedical - Devices
$15.73
$0.89(6.00%)
U.S. Market opens in 6h 21m

BrainsWay Ltd. (BWAY)

Meyka AI Score

Z

Key Financials

Market Cap617M
P/E Ratio41.52
EPS (TTM)$0.39
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$16.08
3 Months$18.57
1 Year Target$22.09

BWAY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BrainsWay Ltd. (BWAY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.46, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $22.09.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 41.52 and a market capitalization of 617M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
6.00%
5-Day Change
4.10%
1-Month Change
9.16%
3-Month Change
-0.51%
6-Month Change
35.72%
Year-to-Date (YTD) Change
65.40%
1-Year Change
170.74%
3-Year Change
1158.40%
5-Year Change
258.31%
All-Time (Max) Change
183.42%

Contact Information

972 2 582 4030
Bynet Building, Jerusalem, JM, 9777518

Company Facts

1,290 Employees
IPO DateApr 17, 2019
CountryIL
Actively Trading

Frequently Asked Questions